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Type 2 diabetes mellitus (T2DM) is an insidious disease characterized by
hyperglycemia and hyperinsulinemia. Among all complications of T2DM, bone
fractures represent a severe alteration of the quality of life of affected
individuals and are cost-effective. One explanation for bone fracture could be
linked to other diabetes complications such as retinopathy and neuropathy,
which increase the incidence of falls. Another explanation could reside in a
direct effect of T2DM on bone resulting in poor “quality” of the bone matrix.[...]
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